openPR Logo
Press release

Bromfenac Sodium Market Outlook: Comprehensive Overview and Projections for 2024

11-26-2024 12:42 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Due to the COVID-19 pandemic, the global Bromfenac Sodium (CAS 91714-93-1) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Original Drug accounting for % of the Bromfenac Sodium (CAS 91714-93-1) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-6H7690/Global_Bromfenac_Sodium_CAS_91714_93_1_Market_Insights_Forecast_to_2028

While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

Bromfenac sodium is an ophthalmic drug for the symptomatic treatment of inflammatory diseases in the external ocular and anterior ocular areas.

Global Bromfenac Sodium (CAS 91714-93-1) Scope and Segment

Bromfenac Sodium (CAS 91714-93-1) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bromfenac Sodium (CAS 91714-93-1) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
• Original Drug
• Generic Drug

Segment by Application
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

BY COMPANY
• Qilu Pharma
• Senju Pharma
• CISEN
• Hi-Tech Pharma
• Apotex Corp.
• Iskon Remedies
• Meizilin Pharma

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-6H7690/global-bromfenac-sodium-cas-91714-93-1

Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bromfenac Sodium Market Outlook: Comprehensive Overview and Projections for 2024 here

News-ID: 3756787 • Views:

More Releases from Valuates Reports

Cross-platform K-12 Education Learning Management Systems Market Set to Surge - Key Insights You Must Know | Valuates Reports
Cross-platform K-12 Education Learning Management Systems Market Set to Surge - …
Cross-platform K-12 Education Learning Management Systems Market The global Cross-platform K-12 Education Learning Management Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032. The North American market for Cross-platform K-12 Education Learning Management Systems is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026-2032. The
Free K-12 Education Learning Management Systems Market Set to Surge - Key Insights You Must Know | Valuates Reports
Free K-12 Education Learning Management Systems Market Set to Surge - Key Insigh …
Free K-12 Education Learning Management Systems Market The global Free K-12 Education Learning Management Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032. The North American market for Free K-12 Education Learning Management Systems is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026-2032. Get
K-12 International Schools Market Set to Surge - Key Insights You Must Know | Valuates Reports
K-12 International Schools Market Set to Surge - Key Insights You Must Know | Va …
K-12 International Schools Market Size The global K-12 International Schools revenue was US$ 7608.1 million in 2022 and is forecast to a readjusted size of US$ 13560 million by 2029 with a CAGR of 8.5% during the review period (2023-2029). An K-12 international school is a K-12 (spoken as "k twelve", "k through twelve", or "k to twelve"), from kindergarten to 12th grade school that promotes international education, in an international environment,
K-12 Education Furniture Market Set to Surge - Key Insights You Must Know | Valuates Reports
K-12 Education Furniture Market Set to Surge - Key Insights You Must Know | Valu …
K-12 Education Furniture Market Size The global K-12 Education Furniture market was valued at US$ 3081 million in 2025 and is anticipated to reach US$ 4361 million by 2032, at a CAGR of 5.2% from 2026 to 2032. The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on K-12 Education Furniture competitive dynamics, regional

All 5 Releases


More Releases for Pharma

Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring